{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:55:42Z","timestamp":1789844142450,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006058","name":"St. Baldrick's Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006058","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ejca.2019.05.001","type":"journal-article","created":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T12:16:16Z","timestamp":1562933776000},"page":"49-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Results from the UK Children's Cancer and Leukaemia Group study of extracranial germ cell tumours in children and adolescents (GCIII)"],"prefix":"10.1016","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7762-686X","authenticated-orcid":false,"given":"Sarita","family":"Depani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Stoneham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Krailo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caihong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejca.2019.05.001_bib1","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S1470-2045(15)00545-8","article-title":"Paediatric extracranial germ-cell tumours","volume":"17","author":"Shaikh","year":"2016","journal-title":"Lancet Oncol"},{"issue":"23","key":"10.1016\/j.ejca.2019.05.001_bib2","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJM198706043162302","article-title":"Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide","volume":"316","author":"Williams","year":"1987","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ejca.2019.05.001_bib3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1200\/JCO.1986.4.2.194","article-title":"High complete response rate in children with advanced germ cell tumors using cisplatin-containing combination chemotherapy","volume":"4","author":"Pinkerton","year":"1986","journal-title":"J Clin Oncol : off J Am Soc Clin Oncol"},{"issue":"9","key":"10.1016\/j.ejca.2019.05.001_bib4","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/1097-0142(19900501)63:9<1657::AID-CNCR2820630902>3.0.CO;2-8","article-title":"Results of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies","volume":"63","author":"Mann","year":"1989","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2019.05.001_bib5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00043426-199903000-00007","article-title":"Late effects of treatment for germ cell tumors during childhood and adolescence","volume":"21","author":"Hale","year":"1999","journal-title":"J pediatric hematol\/oncol"},{"issue":"13","key":"10.1016\/j.ejca.2019.05.001_bib6","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1200\/JCO.2004.08.015","volume":"22","author":"Cushing","year":"2004","journal-title":"J Clin Oncol : off J Am Soc Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2019.05.001_bib7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1023\/A:1008360523160","article-title":"Germ-cell tumors in childhood and adolescence. GPOH MAKEI and the MAHO study groups","volume":"11","author":"Gobel","year":"2000","journal-title":"Ann Oncol : off J European Soc Med Oncol"},{"issue":"22","key":"10.1016\/j.ejca.2019.05.001_bib8","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1200\/JCO.2000.18.22.3809","article-title":"The United Kingdom Children's Cancer Study Group's second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity","volume":"18","author":"Mann","year":"2000","journal-title":"J Clin Oncol : off J Am Soc Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2019.05.001_bib9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1053\/jpsu.2003.50101","article-title":"Excellent outcome in patients with stage I germ cell tumors of the testes: a study of the Children's Cancer Group\/Pediatric Oncology Group","volume":"38","author":"Schlatter","year":"2003","journal-title":"J Pediatr Surg"},{"issue":"4","key":"10.1016\/j.ejca.2019.05.001_bib10","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1200\/JCO.1999.17.4.1212","article-title":"Prognostic factors in children with localized malignant nonseminomatous germ cell tumors","volume":"17","author":"Baranzelli","year":"1999","journal-title":"J Clin Oncol : off J Am Soc Clin Oncol"},{"issue":"12","key":"10.1016\/j.ejca.2019.05.001_bib11","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1002\/1097-0142(19861215)58:12<2594::AID-CNCR2820581207>3.0.CO;2-Z","article-title":"Chemotherapeutic complete remission in patients with metastatic ovarian dysgerminoma. Potential for cure and preservation of reproductive capacity","volume":"58","author":"Gershenson","year":"1986","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.ejca.2019.05.001_bib12","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1200\/JCO.1993.11.12.2314","article-title":"Carboplatin pharmacokinetics in children: the development of a pediatric dosing formula. The United Kingdom Children's Cancer Study Group","volume":"11","author":"Newell","year":"1993","journal-title":"J Clin Oncol : off J Am Soc Clin Oncol"},{"issue":"282","key":"10.1016\/j.ejca.2019.05.001_bib13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"issue":"2","key":"10.1016\/j.ejca.2019.05.001_bib14","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.eururo.2011.05.038","article-title":"EAU guidelines on testicular cancer: 2011 update","volume":"60","author":"Albers","year":"2011","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.ejca.2019.05.001_bib15","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/annonc\/mdm472","article-title":"Assessing prognosis and optimizing treatment in patients with postchemotherapy viable nonseminomatous germ-cell tumors (NSGCT): results of the sCR2 international study","volume":"19","author":"Fizazi","year":"2008","journal-title":"Ann Oncol : off J European Soc Med Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2019.05.001_bib16","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jpedsurg.2015.03.026","article-title":"Surveillance after initial surgery for Stage I pediatric and adolescent boys with malignant testicular germ cell tumors: report from the Children's Oncology Group","volume":"50","author":"Rescorla","year":"2015","journal-title":"J Pediatr Surg"},{"issue":"6","key":"10.1016\/j.ejca.2019.05.001_bib17","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1055\/s-0033-1355427","article-title":"Testicular germ cell tumors in boys <10 years: results of the protocol MAHO 98 in respect to surgery and watch & wait strategy","volume":"225","author":"Gobel","year":"2013","journal-title":"Klin P\u00e4diatr"},{"issue":"5","key":"10.1016\/j.ejca.2019.05.001_bib18","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1200\/JCO.2013.51.1006","article-title":"Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Children's Oncology Group","volume":"32","author":"Billmire","year":"2014","journal-title":"J Clin Oncol : off J Am Soc Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2019.05.001_bib19","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/pbc.24288","article-title":"Is there a role for carboplatin in the treatment of malignant germ cell tumors? A systematic review of adult and pediatric trials","volume":"60","author":"Shaikh","year":"2013","journal-title":"Pediatr Blood Canc"},{"issue":"5","key":"10.1016\/j.ejca.2019.05.001_bib20","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1200\/JCO.1997.15.5.1844","volume":"15","author":"Horwich","year":"1997","journal-title":"J Clin Oncol : off J Am Soc Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2019.05.001_bib21","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s002800000217","article-title":"Carboplatin AUC8 in combination with etoposide and bleomycin in the treatment of intermediate and poor-risk metastatic germ cell tumours: a phase II study","volume":"47","author":"Shamash","year":"2001","journal-title":"Cancer Chemother Pharmacol"},{"issue":"9209","key":"10.1016\/j.ejca.2019.05.001_bib22","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(00)02044-4","article-title":"Circulating plasma platinum more than 10 years after cisplatin treatment for testicular cancer","volume":"355","author":"Gietema","year":"2000","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ejca.2019.05.001_bib23","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1093\/annonc\/mdv369","article-title":"Long-term exposure to circulating platinum is associated with late effects of treatment in testicular cancer survivors","volume":"26","author":"Boer","year":"2015","journal-title":"Ann Oncol : off J European Soc Med Oncol"},{"issue":"18","key":"10.1016\/j.ejca.2019.05.001_bib24","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/jnci\/dji278","article-title":"Second cancers among 40,576 testicular cancer patients: focus on long-term survivors","volume":"97","author":"Travis","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.ejca.2019.05.001_bib25","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/sj.bjc.6690697","article-title":"Dose-related nephrotoxicity of carboplatin in children","volume":"81","author":"English","year":"1999","journal-title":"Br J Canc"},{"key":"10.1016\/j.ejca.2019.05.001_bib26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejca.2016.09.023","article-title":"Determinants of ototoxicity in 451 platinum-treated Dutch survivors of childhood cancer: a DCOG late-effects study","volume":"69","author":"Clemens","year":"2016","journal-title":"Eur J Cancer"},{"issue":"15_suppl","key":"10.1016\/j.ejca.2019.05.001_bib27","doi-asserted-by":"crossref","first-page":"9539","DOI":"10.1200\/jco.2012.30.15_suppl.9539","article-title":"Carboplatin (CBP) versus cisplatin (CP) within prognostic groups in pediatric extracranial malignant germ cell tumors (MGCTs)","volume":"30","author":"Hale","year":"2012","journal-title":"J Clin Oncol"},{"issue":"27","key":"10.1016\/j.ejca.2019.05.001_bib28","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1200\/JCO.2014.60.5337","article-title":"Pediatric and adolescent extracranial germ cell tumors: the road to collaboration","volume":"33","author":"Olson","year":"2015","journal-title":"J Clin Oncol : off J Am Soc Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2019.05.001_bib29","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1200\/JCO.2014.58.3369","article-title":"Revised risk classification for pediatric extracranial germ cell tumors based on 25 years of clinical trial data from the United Kingdom and United States","volume":"33","author":"Frazier","year":"2015","journal-title":"J Clin Oncol : off J Am Soc Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2019.05.001_bib30","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1200\/JCO.1992.10.4.520","article-title":"Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer","volume":"10","author":"Jodrell","year":"1992","journal-title":"J Clin Oncol : off J Am Soc Clin Oncol"},{"issue":"21","key":"10.1016\/j.ejca.2019.05.001_bib31","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1200\/JCO.2000.18.21.3614","article-title":"Prospective validation of renal function-based carboplatin dosing in children with cancer: a United Kingdom Children's Cancer Study Group Trial","volume":"18","author":"Thomas","year":"2000","journal-title":"J Clin Oncol : off J Am Soc Clin Oncol"},{"issue":"11","key":"10.1016\/j.ejca.2019.05.001_bib32","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/0959-8049(95)00382-S","article-title":"Comparison of methods for the estimation of carboplatin pharmacokinetics in paediatric cancer patients","volume":"31a","author":"Peng","year":"1995","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.ejca.2019.05.001_bib33","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/BF00686504","article-title":"Clinical pharmacokinetics of carboplatin in children","volume":"33","author":"Riccardi","year":"1994","journal-title":"Cancer Chemother Pharmacol"},{"issue":"6","key":"10.1016\/j.ejca.2019.05.001_bib34","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/sj.bjc.6604612","article-title":"Estimation of renal function and its potential impact on carboplatin dosing in children with cancer","volume":"99","author":"Chinnaswamy","year":"2008","journal-title":"Br J Canc"},{"issue":"14","key":"10.1016\/j.ejca.2019.05.001_bib35","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.ejca.2015.07.011","article-title":"Carboplatin therapeutic monitoring in preterm and full-term neonates","volume":"51","author":"Veal","year":"2015","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2019.05.001_bib36","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00280-004-0820-3","article-title":"Pharmacokinetically guided dosing of carboplatin in paediatric cancer patients with bilateral nephrectomy","volume":"54","author":"Veal","year":"2004","journal-title":"Cancer Chemother Pharmacol"},{"issue":"21","key":"10.1016\/j.ejca.2019.05.001_bib37","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1200\/JCO.2008.16.0622","article-title":"Mature and immature extracranial teratomas in children: the UK children's cancer study group experience","volume":"26","author":"Mann","year":"2008","journal-title":"J Clin Oncol : off J Am Soc Clin Oncol"},{"issue":"1\u20132","key":"10.1016\/j.ejca.2019.05.001_bib38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00383-002-0884-2","article-title":"Sacrococcygeal teratomas: the UK children's cancer study group's experience. I. Neonatal","volume":"19","author":"Huddart","year":"2003","journal-title":"Pediatr Surg Int"},{"issue":"2","key":"10.1016\/j.ejca.2019.05.001_bib39","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/cncr.29732","article-title":"Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative","volume":"122","author":"Pashankar","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2019.05.001_bib40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejca.2019.03.001","article-title":"A multicentre retrospective cohort study of ovarian germ cell tumours: evidence for chemotherapy de-escalation and alignment of paediatric and adult practice","volume":"113","author":"Newton","year":"2019","journal-title":"Eur J Cancer"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804919302850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804919302850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:25:20Z","timestamp":1760732720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804919302850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":40,"alternative-id":["S0959804919302850"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2019.05.001","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Results from the UK Children's Cancer and Leukaemia Group study of extracranial germ cell tumours in children and adolescents (GCIII)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2019.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}